Neutral
●
PRNewsWire
●
vor 6 Monaten
NEW YORK, March 22, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026, both dates inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline. So what: If you purchased Aquestive securities during the Class Period you may b...